Filing Details
- Accession Number:
- 0001144204-11-014103
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2011-03-10 18:22:54
- Reporting Period:
- 2011-03-08
- Filing Date:
- 2011-03-10
- Accepted Time:
- 2011-03-10 18:22:54
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1137883 | Brainstorm Cell Therapeutics Inc | BCLI | Biological Products, (No Disgnostic Substances) (2836) | 912061050 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1305117 | S Malcolm Taub | C/O Brainstorm Cell Therapeutics Inc., 110 East 59Th Street New York NY 10022 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2011-03-08 | 81,468 | $0.32 | 593,532 | No | 4 | S | Direct | |
Common Stock | Disposition | 2011-03-09 | 50,000 | $0.31 | 543,532 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct | |
No | 4 | S | Direct |
Footnotes
- The transaction was executed in multiple trades at prices ranging from $0.32 to $0.33. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.